Apolipoprotein E and Cognitive Impairment in PTSD: Assessing Genetic Risks and Protections
2021-11
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Apolipoprotein E and Cognitive Impairment in PTSD: Assessing Genetic Risks and Protections
Authors
Published Date
2021-11
Publisher
Type
Thesis or Dissertation
Abstract
This study bridges gaps in the Posttraumatic Stress Disorder (PTSD) literature by providing a rigorous evaluation of the relationships between trauma exposure, PTSD symptoms, Apolipoprotein E (ApoE), and cognitive functioning. A total of 932 U.S. veterans (N=643 males) completed diagnostic interviews of mental health, a cognitive screener, self-reports of PTSD symptom severity and exposure to traumatic events, and blood tests to collect genetic information. Analysis demonstrated that veterans with PTSD perform worse than those without on the Montreal Cognitive Assessment (MoCA), regardless of comorbid depression, and that current PTSD symptoms and Pre-deployment exposure to potentially traumatic events are associated with lower performance on MoCA. Interestingly, veterans with PTSD and a comorbid depressive disorder had higher PTSD symptoms and exposure to potentially traumatic events (PTEs) than veterans with PTSD alone. Higher ApoE cysteine residues per mole were associated with lower PTSD symptoms, indicating its protective nature. Finally, structural equation modeling showed that higher cysteine residues per mole indirectly predicted higher cognition, through lowering PTSD symptoms that negatively affect cognitive functioning. These analyses provide new information regarding the complex relationships between trauma exposure, symptom severity, genetic susceptibility and cognitive function in the context of PTSD in U.S. veterans. Strategies to use these results to improve holistic clinical care and further valuable research include: recommendation for the use of MoCA as a screening tool for cognitive function and referral to other providers, consideration of the impact of Pre-deployment trauma exposure on both current PTSD symptoms and cognitive function, and clarification on the importance of assessing ApoE using cysteine residues per mole to fully interpret risk and protective factors. Finally, these results, taken together using structural equation modelling, illustrate the intricacy of relationships between the many factors contributing to an individual’s presentation with PTSD, an important reminder when working with those experiencing this difficult condition.
Keywords
Description
University of Minnesota Ph.D. dissertation. November 2021. Major: Dentistry. Advisors: Lisa James, Apostolos Georgopoulos. 1 computer file (PDF); ix, 105 pages.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Johnson, Rachel. (2021). Apolipoprotein E and Cognitive Impairment in PTSD: Assessing Genetic Risks and Protections. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/225895.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.